Discover
MREO
Mereo BioPharma Group plc
0.32
2 x 0.24
2 x 0.41
bid
ask
+
0.01
1.67%
2 @ 04:00 PM
0.33 +0.01 (2.17%)
| Ytd | -22.54% | |
| 1y | -88.75% |
0.32
day range
0.34
0.20
52 week range
3.05
| Open | 0.32 | Prev Close | 0.32 | Low | 0.32 | High | 0.34 | Mkt Cap | 51.56M |
| Vol | 1.19M | Avg Vol | 3.45M | EPS | -0.20 | P/E | N/A | Forward P/E | -113.00 |
| Beta | 0.97 | Short Ratio | 8.10 | Inst. Own | 70.58% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 0.29 | 200-d Avg | 0.94 | 1yr Est | 7.04 |
| Income Statement | |||
| Operating Expenses | 8.77M | ||
| Research and Development Expense | 4.75M | ||
| Selling, General and Administrative Expense | 4.02M | ||
| Operating Income | -8.77M | ||
| Interest Expense | 20.00K | ||
| Income Tax Expense | -95.00K | ||
| Net Income | -6.72M | ||
| Net Income Common Stock | -6.72M | ||
| Net Income Common Stock (USD) | -6.72M | ||
| Consolidated Income | -6.72M | ||
| Earnings per Basic Share | -0.05 | ||
| Earnings per Basic Share (USD) | -0.05 | ||
| Earnings per Diluted Share | -0.05 | ||
| Earning Before Interest & Taxes (EBIT) | -6.79M | ||
| Earning Before Interest & Taxes (USD) | -6.79M | ||
| Weighted Average Shares | 801.81M | ||
| Weighted Average Shares Diluted | 801.81M | ||
| Balance Sheet | |||
| Cash and Equivalents | 36.22M | ||
| Cash and Equivalents (USD) | 36.22M | ||
| Current Assets | 40.03M | ||
| Property, Plant & Equipment Net | 199.00K | ||
| Total Assets | 40.61M | ||
| Current Liabilities | 6.18M | ||
| Total Liabilities | 6.56M | ||
| Accumulated Retained Earnings (Deficit) | -507.54M | ||
| Accumulated Other Comprehensive Income | -12.57M | ||
| Shareholders Equity | 34.05M | ||
| Shareholders Equity (USD) | 34.05M | ||
| Assets Non-Current | 580.00K | ||
| Goodwill and Intangible Assets | 381.00K | ||
| Liabilities Non-Current | 383.00K | ||
| Trade and Non-Trade Payables | 3.23M | ||
| Tax Assets | 1.56M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 305.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.61M | ||
| Net Cash Flow from Investing | -300.00K | ||
| Net Cash Flow from Operations | -4.31M | ||
| Effect of Exchange Rate Changes on Cash | -157.00K | ||
| Share Based Compensation | 1.61M | ||